Cancer clinical trials in the region Bourgogne-Franche-Comté
210 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Breast cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Liver and bile duct cancer
#NCT05275478
Locally Advanced
Metastatic
Metastatic Castration-resistant
Other mutation
Systemic Treatment-Naive
Systemic Treatment-Naive
Institut Bergonié (Bordeaux), Centre Léon Bérard (Lyon), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain), Gustave Roussy (Villejuif)
Tango Therapeutics
Phase 2
Lung cancer
#NCT05275478
Locally Advanced
Metastatic
Other mutation
Systemic Treatment-Naive
Systemic Treatment-Naive
Institut Bergonié (Bordeaux), Centre Léon Bérard (Lyon), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain), Gustave Roussy (Villejuif)
Tango Therapeutics
Phase 2
Lung cancer
#NCT06162221
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
KRAS G12C
KRAS non G12C
Other mutation
Systemic Treatment-Naive
Systemic Treatment-Naive
Institut Curie - Paris (Paris), Hôpital Louis Pradel (Bron ), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre Hospitalier Universitaire de Lille - Institut Cœur Poumon (Lille), Centre Hospitalier Universitaire de Nantes (Nantes) (and 1 more...)
Revolution Medicines, Inc.
Phase 2
Pancreas cancer
#NCT05275478
Adenocarcinoma
Other
Locally Advanced
Metastatic
Other mutation
Systemic Treatment-Naive
Systemic Treatment-Naive
Gustave Roussy (Villejuif), Institut Bergonié (Bordeaux), Centre Léon Bérard (Lyon), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
Tango Therapeutics
Phase 2
Pancreas cancer
#NCT04325425
Neuroendocrine tumor
Metastatic
Systemic Treatment-Naive
Chemotherapy
Targeted therapy
CHU Caen Normandie (Caen), Centre hospitalier universitaire François Mitterrand (Dijon), Institut de Cancérologie de Bourgogne - Site de Dijon (Dijon), Centre Hospitalier Universitaire Dupuytren (Limoges), Centre Hospitalier de Saint-Malo (Saint-Malo) (and 2 more...)
CHU Dijon
Phase 2
Pancreas cancer
#NCT02611024
Neuroendocrine tumor
Locally Advanced
Metastatic
Chemotherapy
Systemic Treatment-Naive
Centre Léon Bérard (Lyon), Gustave Roussy (Villejuif)
PharmaMar
Phase 2
Pancreas cancer
#NCT04570943
Adenocarcinoma
Locally Advanced
Systemic Treatment-Naive
Systemic Treatment-Naive
Hôpital Pitié Salpêtrière - AP-HP (Paris), Institut Paoli-Calmettes (Marseille), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Institut du cancer de Montpellier (Montpellier), CHU Nîmes / Institut de cancérologie du Gard (Nîmes) (and 1 more...)
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2
Lung cancer
#NCT04956640
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
KRAS G12C
IUCT Oncopôle (Toulouse), Institut du cancer de Montpellier (Montpellier), Centre Léon Bérard (Lyon), Gustave Roussy (Villejuif), Institut Bergonié (Bordeaux)
Eli Lilly et compagnie
Phase 2
Colon cancer
Rectal cancer
#NCT04956640
Locally Advanced
Metastatic
KRAS G12C
Chemotherapy
Institut Bergonié (Bordeaux), IUCT Oncopôle (Toulouse), Institut du cancer de Montpellier (Montpellier), Centre Léon Bérard (Lyon), Gustave Roussy (Villejuif)
Eli Lilly et compagnie
Phase 2
Pancreas cancer
#NCT04956640
Adenocarcinoma
Locally Advanced
Metastatic
KRAS G12C
Institut Bergonié (Bordeaux), IUCT Oncopôle (Toulouse), Institut du cancer de Montpellier (Montpellier), Centre Léon Bérard (Lyon), Gustave Roussy (Villejuif)
Eli Lilly et compagnie